- Home
- CDIO vs CYN Comparison
CDIO vs CYN Comparison
Compare CDIO & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- CYN
- Stock Information
- Founded
- CDIO 2017
- CYN 2013
- Country
- CDIO United States
- CYN United States
- Employees
- CDIO N/A
- CYN N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- CYN EDP Services
- Sector
- CDIO Health Care
- CYN Technology
- Exchange
- CDIO Nasdaq
- CYN Nasdaq
- Market Cap
- CDIO 7.9M
- CYN 7.5M
- IPO Year
- CDIO N/A
- CYN 2021
- Fundamental
- Price
- CDIO $3.44
- CYN $13.60
- Analyst Decision
- CDIO Buy
- CYN
- Analyst Count
- CDIO 1
- CYN 0
- Target Price
- CDIO $60.00
- CYN N/A
- AVG Volume (30 Days)
- CDIO 57.8K
- CYN 10.2M
- Earning Date
- CDIO 08-11-2025
- CYN 08-06-2025
- Dividend Yield
- CDIO N/A
- CYN N/A
- EPS Growth
- CDIO N/A
- CYN N/A
- EPS
- CDIO N/A
- CYN N/A
- Revenue
- CDIO $19,902.00
- CYN $409,777.00
- Revenue This Year
- CDIO $1,434.82
- CYN $1,162.03
- Revenue Next Year
- CDIO $4,661.91
- CYN $427.83
- P/E Ratio
- CDIO N/A
- CYN N/A
- Revenue Growth
- CDIO N/A
- CYN N/A
- 52 Week Low
- CDIO $3.22
- CYN $3.62
- 52 Week High
- CDIO $53.10
- CYN $1,600.50
- Technical
- Relative Strength Index (RSI)
- CDIO 32.36
- CYN 91.45
- Support Level
- CDIO $3.65
- CYN $3.94
- Resistance Level
- CDIO $4.18
- CYN $4.83
- Average True Range (ATR)
- CDIO 0.31
- CYN 2.40
- MACD
- CDIO 0.12
- CYN 0.61
- Stochastic Oscillator
- CDIO 4.49
- CYN 25.70
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.